EBA
VECT

Eagle Bay Advisors’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Eagle Bay Advisors’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$2K – 1324
2021
Q3 		$2K Buy
200
+100
+100% +$857 ﹤0.01% 1014
2021
Q2 		$2K Buy
+100
New +$1.52K ﹤0.01% 857

Other funds holding VECT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Eagle Bay Advisors's VECT Position: Q4 2021 in Review

Eagle Bay Advisors sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q4 2021, closing a stake of 200 shares — an estimated $2K sold.

Eagle Bay Advisors first reported a position in VECT in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 21 funds tracked by Wall St. Rank hold VECT as of Q4 2021.

  • Eagle Bay Advisors reported no remaining VectivBio Holding AG Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Eagle Bay Advisors sold 200 VectivBio Holding AG Ordinary Shares shares in Q4 2021, an estimated $2K.
  • Eagle Bay Advisors first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 2 quarters.
  • Eagle Bay Advisors's VectivBio Holding AG Ordinary Shares position peaked at $2K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q4 2021.

Based on Eagle Bay Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.